Free tool
Dividend paying stocks
We cover 69 companies that currently pay a dividend. The median market value in the group is $26.99B. Across the group, the median move over the past trading day is −0.37%. 77% of the 69 with a 200-day average trade above it. Price change over the past year runs from −15.6% to +57.2% across the middle 80 percent of the group, with a median of +13.4%.
Other lists in this group
Table
69 of 9,852 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Company | $1.06T | Mega cap | +62.80% | Oct 29, 2026 |
| JNJ | Johnson & Johnson | $658.24B | Mega cap | +55.40% | Oct 13, 2026 |
| ABBV | AbbVie Inc. | $469.68B | Mega cap | +29.36% | Oct 29, 2026 |
| MRK | Merck & Co., Inc. | $377.72B | Mega cap | +86.85% | Oct 29, 2026 |
| NVS | Novartis AG | $299.44B | Mega cap | +27.93% | Oct 27, 2026 |
| AZN | AstraZeneca PLC | $263.12B | Mega cap | +5.09% | Oct 30, 2026 |
| AMGN | Amgen Inc. | $238.06B | Mega cap | +56.24% | Nov 3, 2026 |
| TMO | Thermo Fisher Scientific Inc. | $234.31B | Mega cap | +30.17% | Oct 21, 2026 |
| NVO | Novo Nordisk A/S | $208.63B | Mega cap | −13.32% | Nov 4, 2026 |
| ABT | Abbott Laboratories | $198.74B | Large cap | −11.83% | Oct 14, 2026 |
| GILD | Gilead Sciences, Inc. | $184.47B | Large cap | +32.51% | Oct 29, 2026 |
| PFE | Pfizer Inc. | $161.30B | Large cap | +18.72% | Nov 3, 2026 |
| DHR | Danaher Corporation | $151.40B | Large cap | +5.61% | Oct 20, 2026 |
| BMY | Bristol-Myers Squibb Company | $138.03B | Large cap | +47.01% | Oct 29, 2026 |
| SYK | Stryker Corporation | $126.45B | Large cap | −15.52% | Oct 29, 2026 |
| MDT | Medtronic plc | $117.78B | Large cap | +2.29% | Sep 1, 2026 |
| SNY | Sanofi | $108.83B | Large cap | −4.33% | Oct 30, 2026 |
| MCK | McKesson Corporation | $104.54B | Large cap | +31.57% | Nov 4, 2026 |
| GSK | GSK plc | $104.29B | Large cap | +32.23% | Oct 28, 2026 |
| HCA | HCA Healthcare, Inc. | $94.76B | Large cap | +5.96% | Oct 23, 2026 |
| ELV | Elevance Health, Inc. | $87.30B | Large cap | +32.12% | Oct 21, 2026 |
| REGN | Regeneron Pharmaceuticals, Inc. | $83.89B | Large cap | +39.36% | Oct 28, 2026 |
| CI | The Cigna Group | $74.22B | Large cap | −4.84% | Nov 5, 2026 |
| COR | Cencora, Inc. | $62.55B | Large cap | +13.45% | Nov 4, 2026 |
| TAK | Takeda Pharmaceutical Company Limited | $58.60B | Large cap | +22.68% | Oct 29, 2026 |
| CAH | Cardinal Health, Inc. | $55.45B | Large cap | +61.05% | Nov 5, 2026 |
| BDX | Becton, Dickinson and Company | $51.81B | Large cap | +25.97% | Nov 5, 2026 |
| HUM | Humana Inc. | $46.96B | Large cap | +33.14% | Nov 6, 2026 |
| RPRX | Royalty Pharma plc | $35.71B | Large cap | +74.00% | Nov 4, 2026 |
| ALC | Alcon Inc. | $35.13B | Large cap | −10.24% | Nov 10, 2026 |
| RMD | ResMed Inc. | $34.13B | Large cap | −15.77% | Oct 29, 2026 |
| GEHC | GE HealthCare Technologies Inc. | $33.35B | Large cap | −1.15% | Oct 28, 2026 |
| ZTS | Zoetis Inc. | $32.03B | Large cap | −49.50% | Nov 3, 2026 |
| LH | Labcorp Holdings Inc. | $27.39B | Large cap | +21.14% | Nov 3, 2026 |
| DGX | Quest Diagnostics Incorporated | $26.99B | Large cap | +38.12% | Oct 20, 2026 |
| PHG | Koninklijke Philips N.V. | $26.38B | Large cap | +1.27% | Nov 3, 2026 |
| WST | West Pharmaceutical Services, Inc. | $24.63B | Large cap | +42.61% | Oct 22, 2026 |
| STE | STERIS plc | $23.09B | Large cap | −4.41% | Nov 4, 2026 |
| VTRS | Viatris Inc. | $19.35B | Large cap | +66.19% | Nov 5, 2026 |
| ZBH | Zimmer Biomet Holdings, Inc. | $19.34B | Large cap | −4.32% | Nov 5, 2026 |
| RVTY | Revvity, Inc. | $13.93B | Large cap | +42.93% | Oct 26, 2026 |
| BAX | Baxter International Inc. | $13.70B | Large cap | +8.90% | Oct 29, 2026 |
| FMS | Fresenius Medical Care AG | $12.51B | Large cap | −3.21% | Nov 3, 2026 |
| EHC | Encompass Health Corporation | $11.92B | Large cap | −1.75% | Oct 28, 2026 |
| TECH | Bio-Techne Corporation | $11.35B | Large cap | +29.33% | Nov 9, 2026 |
| UHS | Universal Health Services, Inc. | $10.53B | Large cap | −1.76% | Oct 26, 2026 |
| ENSG | The Ensign Group, Inc. | $10.43B | Large cap | +5.01% | Nov 3, 2026 |
| RDY | Dr. Reddy's Laboratories Limited | $10.18B | Large cap | −14.19% | Oct 22, 2026 |
| QGEN | Qiagen N.V. | $9.01B | Mid cap | −9.65% | Nov 4, 2026 |
| BRKR | Bruker Corporation | $8.69B | Mid cap | +70.56% | Nov 3, 2026 |
| ATR | AptarGroup, Inc. | $8.60B | Mid cap | −1.89% | Oct 29, 2026 |
| CHE | Chemed Corporation | $7.11B | Mid cap | +20.79% | Oct 27, 2026 |
| STVN | Stevanato Group S.p.A. | $6.11B | Mid cap | −0.09% | Nov 5, 2026 |
| TFX | Teleflex Incorporated | $5.88B | Mid cap | +8.06% | Oct 29, 2026 |
| CON | Concentra Group Holdings Parent, Inc. | $4.44B | Mid cap | +50.93% | Nov 5, 2026 |
| OGN | Organon & Co. | $3.62B | Mid cap | +50.67% | Nov 9, 2026 |
| NHC | National HealthCare Corporation | $3.53B | Mid cap | +103.83% | Nov 6, 2026 |
| XRAY | DENTSPLY SIRONA Inc. | $2.18B | Mid cap | −21.61% | Nov 5, 2026 |
| PRGO | Perrigo Company plc | $2.05B | Mid cap | −36.05% | Nov 4, 2026 |
| LMAT | LeMaitre Vascular, Inc. | $1.81B | Small cap | −16.20% | Nov 5, 2026 |
| CNMD | CONMED Corporation | $1.53B | Small cap | −6.91% | Nov 4, 2026 |
| USPH | U.S. Physical Therapy, Inc. | $1.17B | Small cap | −5.67% | Nov 4, 2026 |
| IRMD | IRADIMED CORPORATION | $1.12B | Small cap | +19.80% | Nov 3, 2026 |
| HSTM | HealthStream, Inc. | $840.94M | Small cap | +1.86% | Nov 2, 2026 |
| NRC | NRC Health | $487.06M | Small cap | +45.92% | Oct 26, 2026 |
| KMDA | Kamada Ltd. Ordinary Shares | $483.48M | Small cap | +21.09% | Nov 9, 2026 |
| EMBC | Embecta Corp. | $285.00M | Small cap | −64.70% | Nov 25, 2026 |
| UTMD | Utah Medical Products, Inc. | $225.70M | Small cap | +17.76% | Oct 22, 2026 |
| SPOK | Spok Holdings, Inc. | $217.86M | Small cap | −36.39% | Oct 28, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.